Insider Stock Trading History of Cohen Fred E


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Cohen Fred E since year 2005. The trader's CIK number is 1339358. At the time of this reporting, Cohen Fred E is the Director of Biocryst Pharmaceuticals Inc . (stock ticker symbol BCRX). See this page for all insider trading activities at Biocryst Pharmaceuticals Inc .

Note that in the past Cohen Fred E also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Cohen Fred E since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-09-18 BCRX Biocryst Pharmaceuticals Inc Option Ex 54,250 4.27 231,647
2017-09-18 BCRX Biocryst Pharmaceuticals Inc Sale 54,250 5.42 294,035
2017-05-19 GHDX Genomic Health Inc Option Ex 8,250 14.37 118,552
2017-05-19 GHDX Genomic Health Inc Sale 8,250 29.55 243,746
2017-05-18 GHDX Genomic Health Inc Option Ex 16,500 18.05 297,742
2017-05-18 GHDX Genomic Health Inc Sale 16,500 29.88 493,036
2017-05-16 GHDX Genomic Health Inc Option Ex 8,250 18.13 149,572
2017-05-16 GHDX Genomic Health Inc Sale 8,250 30.68 253,101
2016-01-11 FPRX Five Prime Therapeutics Inc Option Ex 24,695 8.50 209,833
2015-01-08 BCRX Biocryst Pharmaceuticals Inc Option Ex 100,000 1.29 129,000
2012-08-01 GHDX Genomic Health Inc Option Ex 8,250 10.73 88,522
2008-02-19 GHDX Genomic Health Inc Option Ex 5,201 .58 2,995

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cohen Fred E (Director of Biocryst Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.